SLC27A4

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SLC27A4 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated SLC27A4 data layer compared with 22 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher SLC27A4 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SLC27A4 expression acts as an unfavorable survival marker, although some lineages such as HNSC and CCRCC show a favorable association.

HNSC, CCRCC, and LUAD are the cancer types where SLC27A4 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
HNSCOSQuartileAll0.8930.589.00344view →
CCRCCOSMedianAll0.9560.748.00421view →
LUADOSTertileII,III,IV0.3281.000.00220view →
UCECOSTertileIII,IV1.0000.290.0428view →
GBMDFSQuartileAll0.9370.667.0017view →
LSCCDFSMedianAll0.9051.000.0481view →
Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

SLC27A4–HNSC (OS)

Kaplan–Meier survival curve for SLC27A4 mass-spec protein-high vs -low samples in HNSC.

Open the HNSC breakdown →

Exploration